{"id":"https://openalex.org/W4388042385","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1137","title":"1137 MHC Class II peptide on a nanoparticle cancer vaccine induces anti-tumor immune responses","display_name":"1137 MHC Class II peptide on a nanoparticle cancer vaccine induces anti-tumor immune responses","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388042385","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1137"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1137","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1137","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1137","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1251.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1251.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052823238","display_name":"Enya Li","orcid":"https://orcid.org/0000-0003-2310-7479","observed_orcids":["https://orcid.org/0000-0003-2310-7479"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enya Li","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030456173","display_name":"Nina Butkovich","orcid":"https://orcid.org/0009-0003-1097-2647","observed_orcids":["https://orcid.org/0009-0003-1097-2647"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nina Butkovich","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006371204","display_name":"Jo Anne Tucker","orcid":"https://orcid.org/0000-0003-4410-4269","observed_orcids":["https://orcid.org/0000-0003-4410-4269"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jo Anne Tucker","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086973652","display_name":"Edward L. Nelson","orcid":"https://orcid.org/0000-0001-7887-032X","observed_orcids":["https://orcid.org/0000-0001-7887-032X"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward L Nelson","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101261255","display_name":"Szu Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Szu Wang","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I204250578"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1251","last_page":"A1251"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mhc-class-ii-peptides","display_name":"MHC class II peptides","score":0.953000009059906},{"id":"https://openalex.org/keywords/cpg-adjuvant","display_name":"CpG adjuvant","score":0.9340000152587891},{"id":"https://openalex.org/keywords/th1-response","display_name":"Th1 response","score":0.746999979019165},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.777999997138977},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.7860000133514404},{"id":"https://openalex.org/keywords/antigen-delivery","display_name":"antigen delivery","score":0.5109999775886536},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.6639999747276306},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7390000224113464},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.421999990940094},{"id":"https://openalex.org/keywords/balb-c-mice","display_name":"BALB/c mice","score":0.652999997138977},{"id":"https://openalex.org/keywords/th2-bias","display_name":"Th2 bias","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6664420366287231},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.6345718502998352},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6336057782173157},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.6065526008605957},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5724443197250366},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5242367386817932},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.4372163414955139},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.432058721780777},{"id":"https://openalex.org/C2778814158","wikidata":"https://www.wikidata.org/wiki/Q959350","display_name":"MHC class II","level":4,"score":0.4181162714958191},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3469765782356262},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3435107469558716},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3235873579978943},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31103515625},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.30108702182769775},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19314751029014587},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10805156826972961}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.1137","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1137","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1137","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1251.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:a1e79bc860f74951a9056b68c553570f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a1e79bc860f74951a9056b68c553570f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1137","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1137","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1137","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1251.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G823633910","display_name":"Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined Immunotherapy","funder_award_id":"R01EB027797","funder_id":"https://openalex.org/F4320337363","funder_display_name":"National Institute of Biomedical Imaging and Bioengineering"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332688","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771"},{"id":"https://openalex.org/F4320337363","display_name":"National Institute of Biomedical Imaging and Bioengineering","ror":"https://ror.org/00372qc85"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388042385.pdf","grobid_xml":"https://content.openalex.org/works/W4388042385.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W2079696222","https://openalex.org/W2265709812","https://openalex.org/W2998173997","https://openalex.org/W3032578076","https://openalex.org/W3202804227"],"related_works":["https://openalex.org/W7135397343","https://openalex.org/W2104252692","https://openalex.org/W2769671991","https://openalex.org/W4392984550","https://openalex.org/W2265709812","https://openalex.org/W4200051337","https://openalex.org/W2765124987","https://openalex.org/W3018465071","https://openalex.org/W4310937702","https://openalex.org/W994704903"],"abstract_inverted_index":{"Background":[0],"Nanoparticle":[1,43,461,560],"cancer":[2,59,152,462,509],"vaccines":[3],"provide":[4],"advantages":[5],"over":[6],"conventional":[7],"vaccines,":[8,357],"including":[9],"the":[10,81,96,117,177,188,214,227,300,313,324,396,407,410,417,421,435,445,502],"ability":[11],"to":[12,34,40,49,187,226,291,544],"co-deliver":[13],"antigens":[14],"and":[15,21,127,164,170,185,237,250,266,280,315,366,412,440,466],"adjuvants,":[16],"protect":[17],"them":[18],"from":[19,47,213,288],"degradation,":[20],"be":[22],"preferentially":[23],"taken":[24],"up":[25],"by":[26,123,248,256,299,395,434],"dendritic":[27,182,309,582],"cells;":[28],"all":[29],"of":[30,83,119,235,323,363,399,409,420,437,447,482,488,504,581,592],"which":[31],"can":[32,45,102,338],"lead":[33],"better":[35],"anti-tumor":[36,90,121],"immune":[37,91,253,342,383,542],"responses":[38,68,543],"relative":[39],"non-nanoparticle":[41],"formulations.1":[42],"materials":[44],"range":[46,180],"inorganic,":[48],"polymers,":[50],"or":[51,230],"as":[52,143,199],"in":[53,87,176,252,285,312,320,345,486,508,584],"our":[54,358],"case,":[55],"self-assembling":[56,155],"proteins.1":[57],"Most":[58],"vaccination":[60],"strategies":[61],"focus":[62],"on":[63,131,353,374],"stimulating":[64],"CD8":[65],"T":[66,85,105,484,506],"cell":[67,183,254,310],"through":[69],"major":[70],"histocompatibility":[71],"complex":[72],"(MHC)":[73],"Class":[74,113,125,128,149,277,335,354,364,367],"I":[75,126,150,355,365],"recognition.2":[76],"However,":[77],"recent":[78,467],"studies":[79,352,427],"highlight":[80],"importance":[82],"CD4":[84,483],"cells":[86,485,507,583],"supporting":[88],"effective":[89,145,319],"responses.3":[92],"4":[93],"We":[94,239],"evaluate":[95],"hypothesis":[97,386],"that":[98,330,361],"a":[99,104,132,158,200,295,340,375,380,385],"nanoparticle":[100,139,156,196,228,377],"vaccine":[101,201],"induce":[103],"helper":[106],"type-1":[107],"(Th1)":[108],"response":[109,247,297],"against":[110],"an":[111,144,207,221,275,333,372],"MHC":[112,208,276,334,536],"II":[114,129,210,278,336,368,538],"peptide,":[115],"with":[116,162,220,271,350,371,587],"goal":[118],"optimizing":[120],"immunity":[122],"combining":[124],"peptides":[130],"single":[133,376],"nanoparticle.":[134],"Methods":[135],"The":[136,260,403,480],"E2":[137],"protein":[138,160],"has":[140],"been":[141],"utilized":[142],"delivery":[146,202],"platform":[147],"for":[148,168,181,244,562],"targeted":[151,356],"vaccines.5":[153],"This":[154,391],"forms":[157],"hollow":[159],"cage":[161],"exterior":[163,229],"interior":[165],"surfaces":[166],"available":[167],"conjugation,5":[169],"its":[171],"~30":[172],"nm":[173],"diameter":[174],"is":[175,405],"optimal":[178],"size":[179],"uptake":[184],"drainage":[186],"lymph":[189,316,585],"nodes.5":[190],"6":[191],"These":[192],"characteristics":[193],"make":[194],"this":[195,205],"particularly":[197],"attractive":[198],"platform.":[203],"In":[204,578],"study,":[206],"class":[209,537],"(CT26ME1)":[211],"peptide":[212,279,337],"CT26":[215],"murine":[216,241],"colon":[217],"carcinoma,":[218],"along":[219,370],"adjuvant":[222,267],"(CpG),":[223],"were":[224,428],"conjugated":[225],"interior,":[231],"respectively,":[232],"enabling":[233],"co-delivery":[234,362],"antigen":[236,265],"adjuvant.":[238],"evaluated":[240],"(BALB/c)":[242],"splenocytes":[243,289],"antigen-specific":[245,286,382],"IFN-\u03b3":[246,287],"ELISpot":[249],"changes":[251],"subsets":[255],"flow":[257],"cytometry.":[258],"Results":[259],"nanoparticles":[261,331],"remained":[262],"intact":[263],"after":[264],"conjugation.":[268],"Mice":[269],"vaccinated":[270,303],"CpG-CT26ME1-E2":[272,302],"(nanoparticle":[273],"carrying":[274,332],"adjuvant)":[281],"showed":[282],"significant":[283],"increases":[284],"compared":[290],"PBS-treated":[292],"mice,":[293],"indicating":[294],"Th1":[296,341],"elicited":[298],"vaccine.":[301,325],"mice":[304],"also":[305],"exhibited":[306],"overall":[307],"higher":[308],"counts":[311],"spleens":[314],"nodes,":[317],"suggesting":[318],"vivo":[321,579],"processing":[322],"Conclusions":[326],"Our":[327],"results":[328,359],"indicate":[329],"generate":[339],"response,":[343,384],"even":[344],"Th2-biased":[346],"BALB/c":[347],"mice.":[348],"Combined":[349],"previous":[351],"suggest":[360],"peptides,":[369],"adjuvant,":[373],"could":[378],"stimulate":[379],"powerful":[381],"currently":[387],"being":[388],"evaluated.":[389],"Acknowledgements":[390],"work":[392],"was":[393],"supported":[394],"National":[397],"Institutes":[398],"Health":[400],"(NIH)":[401],"(R01EB027797).":[402],"content":[404],"solely":[406],"responsibility":[408],"authors":[411],"does":[413],"not":[414],"necessarily":[415],"represent":[416],"official":[418],"views":[419],"NIH.":[422],"Ethics":[423],"Approval":[424],"All":[425],"animal":[426],"carried":[429],"out":[430],"under":[431],"protocols":[432],"approved":[433],"Institute":[436],"Animal":[438],"Care":[439],"Use":[441],"Committee":[442],"(IACUC)":[443],"at":[444],"University":[446],"California,":[448],"Irvine.":[449],"References":[450],"Liu":[451],"J,":[452,456,477,532],"Miao":[453],"L,":[454,475],"Sui":[455],"Hao":[457],"Y,":[458],"Huang":[459],"G.":[460],"vaccines:":[463],"Design":[464],"considerations":[465],"advances.":[468],"Asian":[469],"J":[470],"Pharm":[471],"Sci.":[472],"2020;15:576\u201390.":[473],"Poncette":[474],"Bluhm":[476],"Blankenstein":[478],"T.":[479],"role":[481,503],"rejection":[487],"solid":[489],"tumors.":[490],"Curr":[491],"Opin":[492],"Immunol.":[493],"2022;74:18\u201324.":[494],"Tay":[495],"RE,":[496],"Richardson":[497],"EK,":[498],"Toh":[499],"HC.":[500],"Revisiting":[501],"CD4+":[505],"immunotherapy\u2014new":[510],"insights":[511],"into":[512],"old":[513],"paradigms.":[514],"Cancer":[515],"Gene":[516],"Therapy.":[517],"2021;28:5\u201317.":[518],"Kreiter":[519],"S,":[520],"Vormehr":[521],"M,":[522,528,530,551],"van":[523],"de":[524],"Roemer":[525],"N,":[526],"Diken":[527],"L\u00f6wer":[529],"Diekmann":[531],"et":[533],"al.":[534],"Mutant":[535],"epitopes":[539],"drive":[540],"therapeutic":[541],"cancer.":[545],"Nature.":[546],"2015;520:692\u2013696.":[547],"Molino":[548],"NM,":[549],"Neek":[550],"Tucker":[552],"JA,":[553,575],"Nelson":[554],"EL,":[555],"Wang":[556],"SW.":[557],"Viral-Mimicking":[558],"Protein":[559],"Vaccine":[561],"Eliciting":[563],"Anti-Tumor":[564],"Responses.":[565],"Biomaterials.":[566],"2016;86:83\u201391.":[567],"Reddy":[568],"ST,":[569],"Rehor":[570],"A,":[571],"Schmoekel":[572],"HG,":[573],"Hubbell":[574],"Swartz":[576],"MA.":[577],"targeting":[580],"nodes":[586],"poly(propylene":[588],"sulfide)":[589],"nanoparticles.":[590],"Journal":[591],"Controlled":[593],"Release.":[594],"2006;112:26\u201334.":[595]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2023-11-01T00:00:00"}